A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
Authors:
- Meng YuanMYMeng Yuan
- Nicholas C. WuNWNicholas C. Wu
- Xueyong ZhuXZXueyong Zhu
- Chang-Chun D. LeeCLChang-Chun D. Lee
- Ray T. Y. SoRSRay T. Y. So
- Huibin LvHLHuibin Lv
- Chris K. P. MokCMChris K. P. Mok
- Ian A. WilsonIWIan A. Wilson
Preprint
Abstract
The outbreak of COVID-19, which is caused by SARS-CoV-2 virus, continues to spread globally, but there is currently very little understanding of the epitopes on the virus. In this study, we have determined the crystal structure of the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein in complex with CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient. CR3022 targets a highly conserved epitope that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding site can only be accessed when at least two RBDs on the trimeric S protein are in the “up” conformation. Overall, this study provides structural and molecular insight into the antigenicity of SARS-CoV-2. ONE SENTENCE SUMMARY: Structural study of a cross-reactive SARS antibody reveals a conserved epitope on the SARS-CoV-2 receptor-binding domain.Keywords
All Related Versions
- Published version: Science, 368 (6491), 630.
This publication has 34 references indexed in Scilit:
- Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2Science, 2020
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Vulnerabilities in coronavirus glycan shields despite extensive glycosylationbioRxiv, 2020
- Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptorbioRxiv, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerging Microbes & Infections, 2020
- IgBLAST: an immunoglobulin variable domain sequence analysis toolNucleic Acids Research, 2013
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLOS Medicine, 2006
- Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor associationProceedings of the National Academy of Sciences, 2004